To determine whether this transcriptional modulation correlated with increased c-Fos and c-Jun protein expression, CLL cells from the same patients were treated with 3 μM ATO for various times, lysed and analyzed by Western blotting. The gene discussed is JUN; the disease is B-cell chronic lymphocytic leukemia.